Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variability within general practitioner prescribing over time.

N Bishop1, T Maling

  • 1Wellington Drug Utilisation Research Unit, Wellington School of Medicine.

The New Zealand Medical Journal
|March 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of a novel, digital physical activity and emotional well-being intervention on health-related quality of life in people with chronic kidney disease: trial design and baseline data from a multicentre prospective, wait-list randomised controlled trial (kidney BEAM).

BMC nephrology·2023
Same author

Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Journal of autism and developmental disorders·2019
Same author

Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

QJM : monthly journal of the Association of Physicians·2019
Same author

The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases.

Orphanet journal of rare diseases·2016
Same author

Diagnostic accuracy of DXA compared to conventional spine radiographs for the detection of vertebral fractures in children.

European radiology·2016
Same author

Quantification of material loss from the neck piece taper junctions of a bimodular primary hip prosthesis. A retrieval study from 27 failed Rejuvenate bimodular hip arthroplasties.

The bone & joint journal·2015
Same journal

Reed diffusers: a potential cause of poisoning in young children in New Zealand.

The New Zealand medical journal·2026
Same journal

Stuffy nights: elevated bedroom carbon dioxide concentrations indicate inadequate ventilation in Wellington homes.

The New Zealand medical journal·2026
Same journal

Cautionary tale of how sodium polystyrene sulfonate caused gut necrosis: a case report.

The New Zealand medical journal·2026
Same journal

Emergency lateral canthotomy and cantholysis for acute globe subluxation.

The New Zealand medical journal·2026
Same journal

Liberation of an incarcerated tibialis posterior tendon following a posterior malleolar ankle fracture: a case report.

The New Zealand medical journal·2026
Same journal

Implementing a cultural safety training plan across medical colleges in Aotearoa New Zealand-looking back, and looking forward.

The New Zealand medical journal·2026
See all related articles

General practitioner prescribing shows 9% year-on-year variability in cost and volume. This intra-general practitioner (GP) prescribing variability should be considered in pharmaceutical budget estimates.

Area of Science:

  • Health Economics
  • General Practice
  • Pharmaceutical Policy

Background:

  • General practitioner (GP) prescribing patterns exhibit variability over time.
  • Understanding this intra-GP prescribing variability is crucial for accurate pharmaceutical budget forecasting.

Purpose of the Study:

  • To quantify the intra-GP prescribing variability in New Zealand general practice.
  • To analyze variability in prescription volume, total cost, and average item cost over time.

Main Methods:

  • Longitudinal analysis of prescription data from two GP samples (regional and national) in New Zealand (1992-94).
  • Utilized reimbursement data and PreMeC prescription analysis (PAS) data.
  • Employed the coefficient of variation to measure intra-GP variability.

Related Experiment Videos

Main Results:

  • Median intra-GP variability was 9% for total cost, 9% for volume, and 5% for average item cost (reimbursement data).
  • Variability was higher with PAS data: 16% for cost, 17% for volume, and 8% for average item cost.
  • Year-on-year variability was estimated at 9% for cost, 9-10% for volume, and 5-6% for average item cost.

Conclusions:

  • Intra-GP prescribing variability is a significant factor in pharmaceutical cost and volume.
  • Pharmaceutical budget estimates should incorporate an approximate 9% variability.
  • Findings highlight the need for dynamic budgeting that accounts for prescribing fluctuations.